The first one is ALS401 - Biotechnology-based Therapeutics taught by Larry Grill.
More information on Larry click here.
Course Description taken from Syllabus:
Advances in genomics, proteomics, recombinant protein technology and structural biology have created opportunities and challenges for the biotech and pharmaceutical industries. This course will provide students with a background of the scientific basis of some key aspects of biotechnology-based drug, biologic and vaccine design, discovery and development process. Students will learn about therapeutic and vaccine targets, and how vaccines and drugs are designed, tested and produced to prevent and/or treat human diseases. They will also learn about development of new vaccines and how this differs from that of small molecules and other biologics, as well as real and perceived issues of safety. This course will consist of lectures, student presentations, and group discussions. Environmental, ethical, regulatory, patent, economic and social issues related to biotechnology-based therapeutics will also be discussed.
Course evaluation: quizzes and a final comprehensive exam, class participation, term paper, and group project (group of 3-4 will organize the plans to develop a biotech company that will produce a therapeutic product that may improve the human condition in some way. A 4 – 6 page group-produced paper will be required.)
The suggested textbook:
Biopharmaceuticals: Biochemistry and Biotechnology. 2nd Edition. 2003. Gary Walsh. Published by John Wiley & Sons, Ltd.
No comments:
Post a Comment